The Latest Breaking News from Stryker

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 81.

Stryker shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Although Stryker has lagged behind the S&P 500 Index over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.16% this morning, stabilizing after yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings…

March S&P 500 E-Mini futures (ESH25) are trending up +0.42% this morning, partially rebounding from yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings reports.

Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

With Stryker gearing up to release its fourth-quarter earnings later this month, analysts expect a significant double-digit growth in earnings.

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.